Biotech | August 17, 2022
Merck and Orna Therapeutics collaborate to advance Orna’s nextgen RNA technology
Collaboration supports multiple discovery efforts, including vaccines
Collaboration supports multiple discovery efforts, including vaccines
Collaboration focuses on developing and implementing real-world research to drive patient access to cancer medicines
Company will invest approximately ¥16 billion to increase production capacity by approximately 70% to ensure a stable supply
The WAVEsystem with the WAVEcontrol 4.0 embedded
The company is focused on therapies such as skinceuticals, gastroenterology, neuropsychiatry, cardiac diabetes care etc.
Advancing to IND-enabling studies with multiple drug candidates
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
Syngene's collaboration with Zoetis started in 2011
Bringing next-gen cannabinoid therapeutics to cancer patients
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
Subscribe To Our Newsletter & Stay Updated
